Vimarsana
Biggest News Aggregation in the World

Page 2 - Turn Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Turn Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Turn Bio Today - Breaking & Trending Today

Here's why I am coining the term "embryo tech" | MIT Technology Review - Vimarsana News

Here's why I am coining the term "embryo tech" | MIT Technology Review

Embryos hold the secrets of regeneration, reproduction, and maybe even human immortality. 

Meet A VC On A Mission To Support Women In Longevity - Vimarsana News

Meet A VC On A Mission To Support Women In Longevity

The field of longevity biotechnology is rapidly evolving. Meet the venture capitalist dedicated to supporting and promoting female founders.

Source: forbes.com
Epigenetic Reprogramming Safe, Effective in Skin Using eTurna™ Delivery System: SEASON Conference Presentation - Vimarsana News

Epigenetic Reprogramming Safe, Effective in Skin Using eTurna™ Delivery System: SEASON Conference Presentation

/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced that its...

Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board - Vimarsana News

Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board

/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced the...

Turn Biotechnologies, Inc.: Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC - Vimarsana News

Turn Biotechnologies, Inc.: Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC

MOUNTAIN VIEW, Calif., March 30, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced